To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SPENTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
439 supporting clones for gene SPEN back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR976999 T-Lymphocytes .a 1 to 563 1 to 564   tiling clone,   564/568
(99 %)
3 diff
(99.5 %id)
AF356524   .a 29 to 12255 1 to 12227 exact tiling clone,   12227/12227
(100 %)
0 diff
(100 %id)
NM_015001.2   .a 29 to 12255 1 to 12227 exact RefSeq,   12227/12227
(100 %)
0 diff
(100 %id)
BF818561 colon_ins .a 250 to 636 10 to 395       386/395
(97 %)
8 diff
(98.0 %id)
BP229693 brain .a 293 to 873 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
AK127577   .a 706 to 3210 1 to 2505   available from FLJ,   2505/2505
(100 %)
1 diff
(100.0 %id)
DA470629   .a 707 to 1262 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
AW993080 breast_normal .a 909 to 1145 19 to 252       234/252
(92 %)
6 diff
(97.7 %id)
CD705687 normal nasopharynx .a 1071 to 1311 14 to 255       242/255
(94 %)
10 diff
(96.1 %id)
AL096858   .a 1111 to 12255 1 to 11145       11145/11145
(100 %)
0 diff
(100 %id)
BI024731 marrow .a 1127 to 1368 1 to 242       242/242
(100 %)
0 diff
(100 %id)
CV358509 breast_normal .a 1254 to 1392 1 to 133       133/133
(100 %)
11 diff
(91.8 %id)
AK092332 brain .a 1456 to 4660 1 to 3205   available from FLJ,   3205/3205
(100 %)
4 diff
(99.9 %id)
DA779006 brain .a 1457 to 2018 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
CN305486 embryonic stem cells, cell lines H1, H7, andH9 .a 1567 to 2013 1 to 447       447/447
(100 %)
2 diff
(99.6 %id)
DA795912 brain .a 1923 to 2464 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
BE816351 breast_normal .a 1944 to 2148 22 to 226       205/232
(88 %)
8 diff
(96.6 %id)
EC535100 Prostate .a 2055 to 2160 1 to 105       105/105
(100 %)
2 diff
(98.1 %id)
BP252520 Kidney .a 2058 to 2640 1 to 582       582/582
(100 %)
5 diff
(99.2 %id)
AW977309   .a 2081 to 2588 508 to 1     Submitted on the opposite strand 508/534
(95 %)
4 diff
(99.3 %id)
AA847799 germinal center B cell .a 2083 to 2595 516 to 4       513/516
(99 %)
0 diff
(100 %id)
DA507063 brain .a 2125 to 2667 2 to 546   capped   545/545
(100 %)
2 diff
(99.7 %id)
DW415465 Liver .a 2204 to 2499 17 to 312       296/312
(94 %)
6 diff
(98.1 %id)
BP312481 mammary gland .a 2214 to 2781 14 to 581       568/581
(97 %)
6 diff
(99.0 %id)
AA761078 germinal center B cell .a 2216 to 2595 383 to 4       380/383
(99 %)
0 diff
(100 %id)
BP238068 Liver .a 2217 to 2829 7 to 619       613/619
(99 %)
6 diff
(99.1 %id)
BP239603 Liver .a 2223 to 2812 1 to 590       590/590
(100 %)
2 diff
(99.7 %id)
DW411713 Liver .a 2266 to 2584 10 to 328       319/328
(97 %)
5 diff
(98.5 %id)
BP238067 Liver .a 2270 to 2832 1 to 563       563/563
(100 %)
3 diff
(99.5 %id)
CR986691 T-Lymphocytes .a 2273 to 3133 1 to 862       862/862
(100 %)
2 diff
(99.8 %id)
AA765498 germinal center B cell .a 2286 to 2521 236 to 1       236/236
(100 %)
2 diff
(99.2 %id)
CR620882 Neuroblastoma Cot 25-normalized .a 2325 to 4997 1 to 2673       2673/2673
(100 %)
0 diff
(100 %id)
AL524034 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 2325 to 3293 1 to 958   AAA   958/1011
(94 %)
21 diff
(98.0 %id)
DW466739 Liver .a 2444 to 2777 17 to 350       334/350
(95 %)
6 diff
(98.3 %id)
DW431644 Liver .a 2461 to 2712 17 to 268       252/268
(94 %)
6 diff
(97.8 %id)
AK022949   .a 2608 to 5017 1 to 2410   available from FLJ,   2410/2410
(100 %)
2 diff
(100.0 %id)
AU128735   .a 2609 to 3135 2 to 528   capped   527/527
(100 %)
2 diff
(99.7 %id)
BX509651   .a 2635 to 3231 1 to 598       598/601
(99 %)
2 diff
(99.7 %id)
DB314739   .a 2654 to 3210 556 to 1       556/557
(99 %)
1 diff
(99.9 %id)
BE782061 eye, retinoblastoma .a 2654 to 3344 1 to 696       696/1209
(57 %)
12 diff
(99.1 %id)
BM720356 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2713 to 3256 1 to 544     Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 544/544
(100 %)
0 diff
(100 %id)
BG005215 placenta_normal .a 2762 to 3182 436 to 17       420/436
(96 %)
0 diff
(100 %id)
AA282306 germinal center B cell .a 2891 to 3364 1 to 472       472/483
(97 %)
4 diff
(99.2 %id)
BX390132 Neuroblastoma Cot 25-normalized .a 3045 to 3938 38 to 928       891/928
(96 %)
5 diff
(99.5 %id)
AW995933 breast_normal .a 3187 to 3656 476 to 9     Submitted on the opposite strand 468/476
(98 %)
0 diff
(100 %id)
BM678912 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 3346 to 3917 580 to 9   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 572/580
(98 %)
0 diff
(100 %id)
AA282307 germinal center B cell .a 3395 to 3817 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
DB326137 brain .a 4096 to 4660 565 to 1       565/568
(99 %)
1 diff
(99.9 %id)
AU150973   .a 4492 to 5017 524 to 1       524/560
(93 %)
6 diff
(99.0 %id)
AB023146 brain .a 6234 to 12255 1 to 6022   available from KIAA,   6022/6022
(100 %)
0 diff
(100 %id)
BM801786 duodenal adenocarcinoma, cell line, small intestine .a 9684 to 10442 1 to 763       763/920
(82 %)
11 diff
(98.9 %id)
BU931965 ovary, teratocarcinoma, cell line .a 9706 to 10615 1 to 920       920/943
(97 %)
21 diff
(97.8 %id)
CD243991 testis .a 9786 to 10484 1 to 705       705/827
(85 %)
9 diff
(99.0 %id)
BX644761   .a 9904 to 10586 1 to 682       682/682
(100 %)
9 diff
(98.7 %id)
BQ719454 sympathetic trunk .a 9983 to 10741 9 to 773       765/952
(80 %)
14 diff
(98.6 %id)
AW371149 breast .a 10026 to 10338 1 to 315       315/315
(100 %)
12 diff
(96.2 %id)
BX956403   .a 10095 to 10588 1 to 494       494/494
(100 %)
0 diff
(100 %id)
BE817976 breast_normal .a 10127 to 10343 1 to 215       215/228
(94 %)
7 diff
(97.0 %id)
BE817974 breast_normal .a 10150 to 10343 1 to 197       197/210
(93 %)
8 diff
(96.2 %id)
BM920612 pooled lung and spleen .a 10218 to 10998 1 to 783       783/1117
(70 %)
29 diff
(97.5 %id)
R83184 liver and spleen .a 10244 to 10548 1 to 304       304/372
(81 %)
1 diff
(99.8 %id)
EB385313 eye, optic nerve .a 10411 to 11234 1 to 824       824/824
(100 %)
0 diff
(100 %id)
AW953204   .a 10439 to 11027 6 to 593       588/593
(99 %)
7 diff
(98.9 %id)
T10117   .a 10439 to 10763 25 to 349       325/349
(93 %)
11 diff
(96.9 %id)
T33276 brain .a 10444 to 10837 1 to 395       395/395
(100 %)
6 diff
(98.5 %id)
T09343   .a 10513 to 10818 1 to 306       306/306
(100 %)
4 diff
(98.7 %id)
AA102009 colon, tumor .a 10523 to 10815 1 to 293       293/293
(100 %)
9 diff
(97.0 %id)
CN305475 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 10584 to 11235 1 to 652       652/652
(100 %)
0 diff
(100 %id)
CV806949 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 10683 to 11544 1 to 875       875/875
(100 %)
20 diff
(97.8 %id)
AA325812 brain, cerebellum .a 10758 to 11085 1 to 329       329/329
(100 %)
4 diff
(98.8 %id)
AW955348   .a 10759 to 11359 1 to 612       612/612
(100 %)
15 diff
(97.6 %id)
R35951 whole brain .a 10762 to 11095 1 to 333       333/457
(72 %)
13 diff
(97.2 %id)
CD626473   .a 10792 to 11507 15 to 731       717/731
(98 %)
8 diff
(99.0 %id)
CA489343   .a 10814 to 11616 28 to 835       808/925
(87 %)
32 diff
(96.6 %id)
CX872441 embryonic stem .a 10880 to 11680 1 to 801       801/801
(100 %)
2 diff
(99.8 %id)
CX872528 embryonic stem .a 10886 to 11665 1 to 780       780/780
(100 %)
0 diff
(100 %id)
BQ329121 lung_normal .a 10915 to 11297 35 to 417       383/418
(91 %)
8 diff
(98.1 %id)
D81616 brain .a 10929 to 11289 1 to 354       354/365
(96 %)
8 diff
(97.9 %id)
R49465 whole brain .a 11897 to 12260 371 to 5       367/417
(88 %)
0 diff
(100 %id)
AA099616 colon, tumor .a 11898 to 12254 358 to 1       358/358
(100 %)
3 diff
(99.2 %id)
T10116   .a 11947 to 12242 296 to 1       296/305
(97 %)
6 diff
(98.1 %id)
AK000882 whole embryo, mainly head .b-u 1 to 1501 2 to 1502   tiling clone, available from FLJ,   1502/1502
(100 %)
1 diff
(100.0 %id)
AU117052 whole embryo, mainly head .b-u 1 to 832 2 to 836   capped   835/837
(99 %)
11 diff
(98.7 %id)
BX371385 Neuroblastoma Cot 25-normalized .b-u 177 to 1093 919 to 5   tiling clone,   915/920
(99 %)
0 diff
(100 %id)
AA884078 pooled .b-u 180 to 601 422 to 1       422/422
(100 %)
1 diff
(99.8 %id)
AI684907 pooled .b-u 244 to 601 359 to 1       359/359
(100 %)
2 diff
(99.5 %id)
BP271325 small intestine .b-u 311 to 892 1 to 582       582/582
(100 %)
0 diff
(100 %id)
CN305485 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b-u 335 to 1037 1 to 705       705/708
(99 %)
3 diff
(99.6 %id)
AA286973 germinal center B cell .b-u 389 to 923 12 to 546       535/546
(97 %)
6 diff
(99.0 %id)
BM786279 Ascites, stomach .b-u 475 to 1166 1 to 692       692/692
(100 %)
0 diff
(100 %id)
BE832607 marrow .b-u 528 to 741 8 to 220       213/220
(96 %)
6 diff
(97.3 %id)
AW996951 breast_normal .b-u 539 to 809 1 to 271       271/271
(100 %)
1 diff
(99.7 %id)
FN124226 breast carcinoma .b-u 543 to 648 110 to 1     Submitted on the opposite strand 110/110
(100 %)
4 diff
(96.4 %id)
AA148920 uterus .b-u 554 to 743 1 to 190       190/193
(98 %)
2 diff
(99.0 %id)
CN305478 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b-u 561 to 1296 1 to 736       736/736
(100 %)
5 diff
(99.4 %id)
BU148450 carcinoma, cell line, Prostate .b-u 650 to 1522 1 to 881   AAA   881/906
(97 %)
20 diff
(97.8 %id)
BM047665 carcinoma, cell line, Prostate .b-u 652 to 1538 1 to 892   AAA   892/912
(97 %)
28 diff
(97.0 %id)
BQ340071 nervous_normal .b-u 740 to 1114 378 to 4       375/429
(87 %)
0 diff
(100 %id)
BX646554   .b-u 753 to 1222 1 to 470       470/470
(100 %)
4 diff
(99.2 %id)
BX491650   .b-u 838 to 1199 17 to 380       364/380
(95 %)
11 diff
(97.2 %id)
AL524033 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b-u 853 to 1777 926 to 5       922/926
(99 %)
0 diff
(100 %id)
FN127341 breast carcinoma .b-u 895 to 996 1 to 103       103/107
(96 %)
3 diff
(97.2 %id)
T06293   .b-u 902 to 1229 10 to 339       330/339
(97 %)
6 diff
(98.3 %id)
AU143978 whole embryo, mainly head .b-u 922 to 1501 580 to 1       580/585
(99 %)
1 diff
(99.9 %id)
AW993044 breast_normal .b-u 967 to 1456 489 to 1     Submitted on the opposite strand 489/489
(100 %)
1 diff
(99.8 %id)
DW417912 Liver .b-u 982 to 1269 17 to 304       288/304
(94 %)
6 diff
(98.1 %id)
AA148921 uterus .b-u 999 to 1441 443 to 1       443/443
(100 %)
1 diff
(99.8 %id)
BG912581 anaplastic oligodendroglioma with 1p/19qloss, brain .b-u 1004 to 1534 35 to 572       538/712
(75 %)
17 diff
(97.7 %id)
BQ182221 Knee, Osteoarthritic Cartilage .b-u 1036 to 1801 777 to 17   AAA   761/766
(99 %)
5 diff
(99.4 %id)
BM719421 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b-u 1055 to 1514 1 to 459   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 459/459
(100 %)
3 diff
(99.4 %id)
FN046676 breast carcinoma .b-u 1079 to 1143 65 to 1     Submitted on the opposite strand 65/66
(98 %)
0 diff
(100 %id)
BP202115 amygdala .b-u 1086 to 1560 1 to 473       473/476
(99 %)
5 diff
(99.0 %id)
BF326946 breast_normal .b-u 1089 to 1521 433 to 2       432/433
(99 %)
0 diff
(100 %id)
AI590602 ovary, tumor, 5 pooled (see description) .b-u 1107 to 1501 395 to 1       395/418
(94 %)
0 diff
(100 %id)
TI_154060030   .b-u 1107 to 1822 766 to 63       704/1021
(68 %)
0 diff
(100 %id)
BE048694 Kidney .b-u 1145 to 1506 363 to 2       362/363
(99 %)
0 diff
(100 %id)
AA219699 brain, neuroepithelial cells .b-u 1160 to 1800 638 to 1       638/638
(100 %)
12 diff
(98.2 %id)
AA286870 germinal center B cell .b-u 1177 to 1501 325 to 1       325/325
(100 %)
0 diff
(100 %id)
BX475963   .b-u 1209 to 1693 1 to 485       485/485
(100 %)
0 diff
(100 %id)
AW003900 brain, glioblastoma (pooled) .b-u 1219 to 1796 578 to 1       578/578
(100 %)
0 diff
(100 %id)
BE219154 carcinoid, lung .b-u 1241 to 1746 1 to 506     Submitted on the opposite strand 506/506
(100 %)
0 diff
(100 %id)
BE503978 carcinoid, lung .b-u 1243 to 1684 1 to 442     Submitted on the opposite strand 442/442
(100 %)
1 diff
(99.8 %id)
BM682757 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b-u 1265 to 1505 255 to 15   fully sequenced, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 241/255
(94 %)
0 diff
(100 %id)
CA419912 Bone, Human Chondrosarcoma Cell Line .b-u 1267 to 1816 548 to 1       548/548
(100 %)
3 diff
(99.5 %id)
BE009482 breast_normal .b-u 1297 to 1419 126 to 5     Submitted on the opposite strand 122/126
(96 %)
0 diff
(100 %id)
AI240051 pooled .b-u 1334 to 1785 443 to 1       443/514
(86 %)
21 diff
(96.0 %id)
BP250059 hippocampus .b-u 1354 to 1935 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
AI418314 brain, glioblastoma (pooled) .b-u 1357 to 1796 438 to 1       438/438
(100 %)
4 diff
(99.1 %id)
AI252775 pooled .b-u 1365 to 1788 424 to 1       424/424
(100 %)
1 diff
(99.8 %id)
AI376635 pooled .b-u 1371 to 1805 434 to 1       434/434
(100 %)
2 diff
(99.6 %id)
AW014659   .b-u 1372 to 1799 445 to 18   AAA   428/428
(100 %)
2 diff
(99.6 %id)
FN062550 breast carcinoma .b-u 1393 to 1514 1 to 122       122/122
(100 %)
1 diff
(99.2 %id)
AI221483 pooled .b-u 1449 to 1799 351 to 1       351/351
(100 %)
0 diff
(100 %id)
BP284648 bone marrow .b-u 1451 to 2047 1 to 596   tiling clone,   596/596
(100 %)
1 diff
(99.9 %id)
AA897304 pooled .b-u 1463 to 1804 342 to 1       342/342
(100 %)
0 diff
(100 %id)
AA304131 aorta .b-u 1465 to 1748 1 to 288       288/290
(99 %)
5 diff
(98.3 %id)
AA826282 germinal center B cell .b-u 1587 to 1804 224 to 7       218/224
(97 %)
0 diff
(100 %id)
AA906387 pooled .b-u 1593 to 1805 213 to 1       213/213
(100 %)
0 diff
(100 %id)
FN135824 breast carcinoma .b-u 1740 to 1801 61 to 1     Submitted on the opposite strand 61/62
(98 %)
3 diff
(95.2 %id)
BF932490 nervous_tumor .b-u 1828 to 2284 457 to 1     Submitted on the opposite strand 457/457
(100 %)
2 diff
(99.6 %id)
AA312933   .b-u 1851 to 2032 1 to 182       182/184
(98 %)
1 diff
(99.5 %id)
BF929969 nervous_tumor .b-u 1883 to 2284 402 to 1     Submitted on the opposite strand 402/403
(99 %)
5 diff
(98.8 %id)
AW390252 stomach .b-u 1926 to 2591 1 to 666   tiling clone,   666/668
(99 %)
14 diff
(98.0 %id)
AW390279 stomach .b-u 1958 to 2518 12 to 570       559/570
(98 %)
6 diff
(99.0 %id)
R16437 liver and spleen .b-u 1964 to 2312 1 to 354       354/405
(87 %)
8 diff
(98.1 %id)
BI039554 nervous_tumor .b-u 1974 to 2286 327 to 14       314/327
(96 %)
0 diff
(100 %id)
CD676315 eye, lens .b-u 2272 to 2870 1 to 599   tiling clone,   599/599
(100 %)
0 diff
(100 %id)
BF905891 marrow .b-u 2359 to 2895 537 to 1     Submitted on the opposite strand 537/537
(100 %)
5 diff
(99.1 %id)
AA481652 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b-u 2390 to 2629 1 to 240       240/240
(100 %)
2 diff
(99.2 %id)
AW390319 stomach .b-u 2395 to 2869 487 to 12       476/487
(97 %)
0 diff
(100 %id)
BF925224 nervous_tumor .b-u 2398 to 2899 503 to 2     Submitted on the opposite strand 502/503
(99 %)
0 diff
(100 %id)
AA286766 germinal center B cell .b-u 2425 to 2826 1 to 401       401/401
(100 %)
2 diff
(99.6 %id)
BP282639 bone marrow .b-u 2426 to 3005 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
AW502638 lymph .b-u 2467 to 2890 7 to 430       424/430
(98 %)
1 diff
(99.8 %id)
CF135347 lymph .b-u 2467 to 2823 7 to 363       357/363
(98 %)
2 diff
(99.5 %id)
TI_154158138   .b-u 2467 to 3012 84 to 628       545/545
(100 %)
6 diff
(98.9 %id)
CF143177 lymph .b-u 2558 to 2976 1 to 419       419/419
(100 %)
3 diff
(99.3 %id)
TI_154174440   .b-u 2563 to 3176 85 to 697   tiling clone,   613/614
(99 %)
9 diff
(98.6 %id)
AI017101 pooled .b-u 2610 to 3010 401 to 1       401/401
(100 %)
0 diff
(100 %id)
AA287631.
matches multiple genes
germinal center B cell .b-u 2630 to 3006 377 to 1     also hits gene mamy 377/377
(100 %)
4 diff
(99.0 %id)
BF964458 nervous_normal .b-u 2710 to 2838 10 to 139       130/139
(93 %)
6 diff
(95.7 %id)
BI033197 nervous_normal .b-u 2711 to 2913 1 to 196       196/196
(100 %)
11 diff
(94.4 %id)
BI033194 nervous_normal .b-u 2734 to 2913 1 to 176       176/176
(100 %)
9 diff
(94.9 %id)
GD156325   .b-u 2760 to 3007 1 to 249   AAA   249/249
(100 %)
16 diff
(93.6 %id)
AI351928 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .b-u 2772 to 3007 236 to 1       236/236
(100 %)
0 diff
(100 %id)
CN305481 embryonic stem cells, cell lines H1, H7, andH9 .b-u 2839 to 3074 1 to 236   tiling clone,   236/236
(100 %)
1 diff
(99.6 %id)
BX481161   .b-u 3194 to 3703 1 to 510   tiling clone,   510/510
(100 %)
0 diff
(100 %id)
BQ300533 bladder_tumor .b-u 3225 to 3672 1 to 450       450/450
(100 %)
3 diff
(99.4 %id)
CR985091 T-Lymphocytes .b-u 3359 to 3732 1 to 374       374/374
(100 %)
0 diff
(100 %id)
BI058854 placenta_normal .b-u 3403 to 3821 451 to 33       419/451
(92 %)
0 diff
(100 %id)
BI046936 prostate_normal .b-u 3426 to 3937 1 to 509       509/520
(97 %)
24 diff
(95.4 %id)
BF996382 placenta_normal .b-u 3428 to 3859 1 to 432       432/432
(100 %)
5 diff
(98.9 %id)
BI025838 marrow .b-u 3464 to 3722 27 to 287       261/288
(90 %)
7 diff
(97.6 %id)
BI045581 prostate_normal .b-u 3636 to 4296 661 to 2   tiling clone,   660/662
(99 %)
0 diff
(100 %id)
BI046962 prostate_normal .b-u 3668 to 4296 627 to 3       625/636
(98 %)
0 diff
(100 %id)
BE082651 breast .b-u 3698 to 4313 9 to 624       616/624
(98 %)
6 diff
(99.1 %id)
BF332028 breast .b-u 3707 to 4210 506 to 1       506/549
(92 %)
16 diff
(97.1 %id)
BE082926 breast .b-u 3708 to 4313 1 to 605       605/605
(100 %)
8 diff
(98.7 %id)
AI207502 Liver .b-u 3709 to 4271 563 to 1   tiling clone,   563/563
(100 %)
1 diff
(99.9 %id)
BI046619 prostate_normal .b-u 3811 to 4264 462 to 14       449/462
(97 %)
0 diff
(100 %id)
BE715668 head_neck .b-u 3812 to 4087 287 to 12       276/295
(93 %)
0 diff
(100 %id)
CV424129 colon_ins .b-u 3846 to 4029 184 to 1     Submitted on the opposite strand 184/366
(50 %)
2 diff
(99.5 %id)
BF849936 lung_normal .b-u 3904 to 4296 393 to 2     Submitted on the opposite strand 392/393
(99 %)
0 diff
(100 %id)
BF847732 lung_normal .b-u 3920 to 4190 271 to 1     Submitted on the opposite strand 271/271
(100 %)
5 diff
(98.2 %id)
CN305477 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b-u 3975 to 4690 1 to 716   tiling clone,   716/716
(100 %)
3 diff
(99.6 %id)
W90490 liver and spleen .b-u 3975 to 4255 10 to 289   fully sequenced,   280/289
(96 %)
7 diff
(97.6 %id)
AA004853 liver and spleen .b-u 3980 to 4413 1 to 440   fully sequenced,   440/440
(100 %)
10 diff
(97.8 %id)
R01981 liver and spleen .b-u 3990 to 4302 1 to 318       318/318
(100 %)
11 diff
(96.6 %id)
BQ331469 lung_tumor .b-u 4001 to 4230 1 to 231       231/231
(100 %)
8 diff
(96.6 %id)
BU430254 lymph .b-u 4073 to 4576 7 to 510       504/510
(98 %)
1 diff
(99.9 %id)
TI_154151577   .b-u 4073 to 4694 79 to 696   tiling clone,   618/661
(93 %)
10 diff
(98.5 %id)
CF142608 lymph .b-u 4085 to 4667 8 to 589       582/589
(98 %)
4 diff
(99.4 %id)
CF135259 lymph .b-u 4085 to 4640 8 to 563       556/563
(98 %)
4 diff
(99.3 %id)
TI_154163476   .b-u 4085 to 4858 72 to 859       788/1428
(55 %)
43 diff
(97.0 %id)
TI_154173700   .b-u 4085 to 4934 93 to 954       862/1195
(72 %)
51 diff
(95.8 %id)
CD626472   .b-u 4189 to 4687 1 to 499       499/511
(97 %)
4 diff
(99.3 %id)
CD626471   .b-u 4190 to 4687 509 to 12       498/509
(97 %)
0 diff
(100 %id)
T96987 liver and spleen .b-u 4221 to 4530 317 to 4       314/386
(81 %)
0 diff
(100 %id)
W90491 liver and spleen .b-u 4225 to 4562 341 to 1   fully sequenced,   341/341
(100 %)
2 diff
(99.5 %id)
BU429142 lymph .b-u 4227 to 4528 8 to 309       302/309
(97 %)
6 diff
(98.1 %id)
TI_154150127   .b-u 4227 to 5022 80 to 863       784/785
(99 %)
74 diff
(90.6 %id)
AA004662 liver and spleen .b-u 4388 to 4562 173 to 1   fully sequenced,   173/173
(100 %)
1 diff
(99.5 %id)
AW502012 lymph .b-u 4443 to 4553 1 to 111       111/111
(100 %)
5 diff
(95.5 %id)
AW501942 lymph .b-u 4443 to 4810 1 to 368       368/368
(100 %)
4 diff
(99.0 %id)
AW502240 lymph .b-u 4443 to 5014 1 to 572       572/572
(100 %)
5 diff
(99.2 %id)
CF143396 lymph .b-u 4443 to 4835 1 to 393       393/393
(100 %)
4 diff
(99.0 %id)
CF143362 lymph .b-u 4443 to 5025 1 to 583       583/583
(100 %)
8 diff
(98.7 %id)
CF143380 lymph .b-u 4443 to 5041 1 to 599       599/599
(100 %)
4 diff
(99.4 %id)
CF147507 lymph .b-u 4450 to 5023 1 to 575       575/575
(100 %)
2 diff
(99.7 %id)
TI_154157129   .b-u 4450 to 4947 95 to 593       499/500
(99 %)
14 diff
(97.2 %id)
TI_154157661   .b-u 4450 to 5034 80 to 664       585/585
(100 %)
1 diff
(99.9 %id)
TI_154174757   .b-u 4450 to 5114 80 to 744       665/665
(100 %)
10 diff
(98.5 %id)
TI_154174772   .b-u 4450 to 5114 80 to 744       665/665
(100 %)
3 diff
(99.6 %id)
TI_154174830   .b-u 4450 to 4939 88 to 579       492/690
(71 %)
10 diff
(98.6 %id)
TI_154185367   .b-u 4450 to 5030 84 to 670       587/1222
(48 %)
92 diff
(92.5 %id)
TI_154185434   .b-u 4450 to 5224 90 to 868       779/974
(79 %)
21 diff
(97.9 %id)
BU183794 melanotic melanoma, skin .b-u 4461 to 5309 1 to 855       855/861
(99 %)
11 diff
(98.8 %id)
CR980404 T-Lymphocytes .b-u 4484 to 5327 1 to 845   tiling clone,   845/845
(100 %)
1 diff
(99.9 %id)
CR995789 T-Lymphocytes .b-u 4485 to 5214 1 to 731       731/735
(99 %)
2 diff
(99.8 %id)
T05241   .b-u 4518 to 4890 376 to 1       376/376
(100 %)
5 diff
(98.7 %id)
AW504650 lymph .b-u 4654 to 5174 1 to 521       521/521
(100 %)
3 diff
(99.5 %id)
TI_154160926   .b-u 4661 to 5309 76 to 719       644/708
(90 %)
20 diff
(97.2 %id)
CN305487 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b-u 4674 to 5227 1 to 554       554/554
(100 %)
0 diff
(100 %id)
CN305482 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b-u 4692 to 5182 1 to 491       491/496
(98 %)
1 diff
(99.8 %id)
CR993025 T-Lymphocytes .b-u 4736 to 5268 1 to 535       535/540
(99 %)
3 diff
(99.5 %id)
BQ301568 bocio_tumor .b-u 4750 to 5349 638 to 35       604/638
(94 %)
0 diff
(100 %id)
CB960238 Human Placenta, placenta .b-u 4883 to 5613 26 to 762       737/777
(94 %)
8 diff
(99.0 %id)
AW387053 stomach .b-u 5117 to 5417 324 to 24       301/346
(86 %)
0 diff
(100 %id)
CR997056 T-Lymphocytes .b-u 5216 to 5990 1 to 777   tiling clone,   777/778
(99 %)
4 diff
(99.5 %id)
AL703571 human skeletal muscle .b-u 5287 to 5832 1 to 547       547/547
(100 %)
2 diff
(99.7 %id)
CF136838 lymph .b-u 5293 to 5805 7 to 519       513/519
(98 %)
0 diff
(100 %id)
TI_154166065   .b-u 5293 to 6040 79 to 833       755/757
(99 %)
34 diff
(95.6 %id)
EL594620 epidermis, skin .b-u 5369 to 5827 460 to 1     Submitted on the opposite strand 460/466
(98 %)
6 diff
(98.8 %id)
BQ361731 ovary .b-u 5389 to 5515 1 to 123       123/123
(100 %)
6 diff
(95.2 %id)
BG984707 colon_normal .b-u 5407 to 5747 1 to 345       345/345
(100 %)
20 diff
(94.3 %id)
BI009603 kidney_tumor .b-u 5416 to 5777 16 to 381       366/381
(96 %)
6 diff
(98.5 %id)
BQ326536 colon_normal .b-u 5435 to 5576 1 to 141       141/144
(97 %)
12 diff
(91.7 %id)
BQ953593 sciatic nerve .b-u 5446 to 6233 1 to 796       796/909
(87 %)
10 diff
(98.9 %id)
BF762078 colon_est .b-u 5531 to 5912 398 to 18     Submitted on the opposite strand 381/405
(94 %)
0 diff
(100 %id)
AI763398 B-cell, chronic lymphotic leukemia .b-u 5615 to 6077 458 to 1       458/458
(100 %)
5 diff
(99.0 %id)
EL595032 epidermis, skin .b-u 5684 to 5989 22 to 327       306/341
(89 %)
4 diff
(98.9 %id)
CD172437 White Matter .b-u 5716 to 6447 1 to 744   tiling clone,   744/919
(80 %)
17 diff
(98.2 %id)
CV338067 kidney_tumor .b-u 5748 to 5973 246 to 21     Submitted on the opposite strand 226/248
(91 %)
0 diff
(100 %id)
BF924313 nervous_tumor .b-u 5761 to 6201 441 to 1     Submitted on the opposite strand 441/441
(100 %)
2 diff
(99.6 %id)
CD626475   .b-u 5975 to 6188 225 to 12       214/225
(95 %)
0 diff
(100 %id)
CD626476   .b-u 5975 to 6188 1 to 214       214/228
(93 %)
0 diff
(100 %id)
CD626477   .b-u 5975 to 6188 1 to 216       216/231
(93 %)
2 diff
(99.2 %id)
CD626478   .b-u 5975 to 6188 225 to 14       212/225
(94 %)
0 diff
(100 %id)
CD626479   .b-u 5975 to 6188 1 to 214       214/229
(93 %)
0 diff
(100 %id)
CD626480   .b-u 5975 to 6188 227 to 14       214/227
(94 %)
0 diff
(100 %id)
CD626481   .b-u 5975 to 6188 1 to 214       214/229
(93 %)
0 diff
(100 %id)
CD626482   .b-u 5975 to 6188 226 to 13       214/226
(94 %)
0 diff
(100 %id)
BI009620 kidney_tumor .b-u 5979 to 6321 345 to 3       343/345
(99 %)
0 diff
(100 %id)
BI009659 kidney_tumor .b-u 5979 to 6329 390 to 40       351/390
(90 %)
0 diff
(100 %id)
BQ320088 colon .b-u 6016 to 6335 351 to 31       321/398
(80 %)
22 diff
(94.5 %id)
CA396321 eye, RPE/choroid .b-u 6017 to 6601 11 to 595       585/595
(98 %)
6 diff
(99.0 %id)
AW503535 lymph .b-u 6067 to 6453 5 to 391       387/391
(98 %)
6 diff
(98.5 %id)
TI_154159451   .b-u 6070 to 6535 82 to 547       466/467
(99 %)
8 diff
(98.3 %id)
BM470910 leiomyosarcoma, uterus .b-u 6113 to 7024 1 to 945       945/1065
(88 %)
25 diff
(97.7 %id)
CR983003 T-Lymphocytes .b-u 6193 to 6890 1 to 698   tiling clone,   698/698
(100 %)
0 diff
(100 %id)
CN305480 embryonic stem cells, cell lines H1, H7, andH9 .b-u 6276 to 6729 1 to 453       453/453
(100 %)
2 diff
(99.6 %id)
BF762464 colon_est .b-u 6444 to 6758 61 to 375       315/375
(84 %)
6 diff
(98.4 %id)
EC524962 Prostate .b-u 6462 to 6556 93 to 1       93/93
(100 %)
3 diff
(96.8 %id)
TI_154134112   .b-u 6778 to 7418 736 to 89   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 648/1203
(53 %)
17 diff
(98.6 %id)
DA401057 thalamus .c 1 to 578 2 to 580   tiling clone, capped   579/579
(100 %)
1 diff
(99.9 %id)
Z19242 leg muscle, skeletal muscle .c 345 to 682 1 to 338   tiling clone,   338/338
(100 %)
1 diff
(99.8 %id)
Z19241 leg muscle, skeletal muscle .c 469 to 791 322 to 2   tiling clone,   321/326
(98 %)
0 diff
(100 %id)
DB312152 thalamus .c 1426 to 1973 550 to 3   tiling clone,   548/550
(99 %)
0 diff
(100 %id)
BP264799 muscle .d 1 to 801 1 to 798   tiling clone,   798/800
(99 %)
17 diff
(97.9 %id)
BQ213242 melanotic melanoma, skin .d 716 to 1606 1 to 892   tiling clone,   892/892
(100 %)
6 diff
(99.4 %id)
BG199008   .d 1565 to 2234 682 to 19   tiling clone, Submitted on the opposite strand 664/859
(77 %)
24 diff
(97.3 %id)
AA629549 lung, lung carcinoma .d 1904 to 2228 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
BM457371 embryonal carcinoma, cell line, testis .e 1 to 464 1 to 467   tiling clone,   467/1249
(37 %)
18 diff
(98.6 %id)
DA239293 brain .e 65 to 638 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
BQ881109 dorsal root ganglia .e 105 to 941 1 to 850   tiling clone,   850/958
(88 %)
16 diff
(98.4 %id)
BM454742 embryonal carcinoma, cell line, testis .f 1 to 895 1 to 901   tiling clone,   901/999
(90 %)
11 diff
(98.9 %id)
AL691572   .f 298 to 1022 1 to 724   tiling clone, to resequence,   724/724
(100 %)
3 diff
(99.6 %id)
BF673588 Prostate .f 771 to 1404 1 to 631   tiling clone,   631/631
(100 %)
10 diff
(98.5 %id)
AL691573   .f 2319 to 2446 162 to 34   tiling clone, to resequence, AAA   129/129
(100 %)
3 diff
(97.7 %id)
CK429671 eye, lacrimal gland .g-u 1 to 609 1 to 609   tiling clone,   609/609
(100 %)
0 diff
(100 %id)
AA767332 germinal center B cell .g-u 1135 to 1359 229 to 5   tiling clone,   225/233
(96 %)
0 diff
(100 %id)
TI_149287929   .h 1 to 832 924 to 95 E3* tiling clone, AAA   830/964
(86 %)
10 diff
(99.0 %id)
BM970104 lung .h 125 to 832 726 to 19   AAA   708/708
(100 %)
0 diff
(100 %id)
BQ063219 lymph, lymphoma, cell line .h 202 to 1149 1 to 961   tiling clone,   961/1041
(92 %)
24 diff
(97.7 %id)
AI693158 carcinoid, lung .h 859 to 1401 1 to 543   tiling clone, Submitted on the opposite strand 543/543
(100 %)
0 diff
(100 %id)
AA887868 colon, colon tumor RER+ .h 861 to 1107 1 to 247     Submitted on the opposite strand 247/247
(100 %)
4 diff
(98.4 %id)
BF769991 epid_tumor .h 1003 to 1274 272 to 1     Submitted on the opposite strand 272/272
(100 %)
0 diff
(100 %id)
BQ645976 hepatocellular carcinoma, cell line, Liver .h 1026 to 1857 11 to 858       848/921
(92 %)
39 diff
(95.8 %id)
CX763150 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .h 1041 to 1606 1 to 566     Submitted on the opposite strand 566/566
(100 %)
1 diff
(99.9 %id)
H74133 liver and spleen .h 1048 to 1354 16 to 322       307/352
(87 %)
7 diff
(98.1 %id)
W88439 liver and spleen .h 1048 to 1361 14 to 329   fully sequenced,   316/329
(96 %)
13 diff
(96.1 %id)
AA004363 liver and spleen .h 1054 to 1361 1 to 308       308/331
(93 %)
6 diff
(98.2 %id)
H73058 liver and spleen .h 1059 to 1361 318 to 16       303/321
(94 %)
0 diff
(100 %id)
BY795528 eye .h 1096 to 1692 1 to 597       597/597
(100 %)
0 diff
(100 %id)
BP430024   .h 1108 to 1444 1 to 337       337/337
(100 %)
2 diff
(99.5 %id)
BM831808 stomach .h 1121 to 1543 1 to 423       423/423
(100 %)
0 diff
(100 %id)
BM832329 stomach .h 1121 to 1475 1 to 355       355/355
(100 %)
0 diff
(100 %id)
BM834839 stomach .h 1121 to 1450 1 to 329       329/329
(100 %)
1 diff
(99.7 %id)
W89203 liver and spleen .h 1122 to 1207 86 to 1   fully sequenced,   86/86
(100 %)
0 diff
(100 %id)
BQ424482 leiomyosarcoma, uterus .h 1137 to 1872 1 to 751       751/920
(81 %)
13 diff
(98.6 %id)
AA295573 Pancreas .h 1139 to 1522 1 to 383       383/383
(100 %)
2 diff
(99.5 %id)
AA384953 thyroid gland .h 1139 to 1372 1 to 234       234/234
(100 %)
0 diff
(100 %id)
AW956790   .h 1140 to 1744 1 to 594       594/595
(99 %)
19 diff
(96.9 %id)
CN305476 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .h 1156 to 1570 1 to 415       415/415
(100 %)
3 diff
(99.3 %id)
CN305479 embryonic stem cells, DMSO-treated H9 cellline .h 1160 to 1769 1 to 611       611/611
(100 %)
5 diff
(99.2 %id)
D78834 placenta .h 1164 to 1500 1 to 338       338/338
(100 %)
5 diff
(98.6 %id)
D79139 placenta .h 1164 to 1482 1 to 319       319/319
(100 %)
3 diff
(99.1 %id)
D79168 placenta .h 1164 to 1552 1 to 385       385/385
(100 %)
5 diff
(98.8 %id)
T50937 Liver .h 1208 to 1518 1 to 311       311/311
(100 %)
7 diff
(97.8 %id)
TI_154137190   .h 1245 to 1991 821 to 80   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 742/876
(84 %)
8 diff
(99.1 %id)
BY996900   .h 1255 to 1986 3 to 734       732/734
(99 %)
6 diff
(99.2 %id)
BX091467 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1261 to 1933 1 to 673       673/673
(100 %)
0 diff
(100 %id)
AA479332 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1261 to 1759 1 to 499       499/499
(100 %)
0 diff
(100 %id)
BM687568 eye, eye anterior segment .h 1261 to 1802 9 to 549   fully sequenced,   541/549
(98 %)
5 diff
(99.1 %id)
AA262827 germinal center B cell .h 1262 to 1675 1 to 412       412/412
(100 %)
4 diff
(99.1 %id)
R29735   .h 1295 to 1435 1 to 135       135/135
(100 %)
4 diff
(97.1 %id)
D81571 brain .h 1299 to 1586 11 to 297       287/303
(94 %)
2 diff
(99.4 %id)
BI262351 lymph, lymphoma, cell line .h 1310 to 1994 688 to 1       688/688
(100 %)
2 diff
(99.8 %id)
BQ000654 Fibrosarcoma .h 1314 to 1991 696 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 678/692
(97 %)
0 diff
(100 %id)
CB216414 normal endometrium, mid-secretory phase,cycle day 23, uterus .h 1321 to 1926 1 to 606       606/606
(100 %)
0 diff
(100 %id)
BM992098 Bone, Subchondral Bone .h 1328 to 1991 682 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 664/664
(100 %)
0 diff
(100 %id)
BU631715 cell lines, Chondrosarcoma .h 1328 to 1991 682 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 664/664
(100 %)
0 diff
(100 %id)
BU625018 cell lines, Enchondroma .h 1328 to 1991 682 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 664/664
(100 %)
0 diff
(100 %id)
W38777 parathyroid gland, parathyroid tumor .h 1341 to 1751 1 to 418       418/440
(95 %)
18 diff
(96.0 %id)
CV338040 nervous_tumor .h 1353 to 1720 1 to 369       369/369
(100 %)
38 diff
(89.8 %id)
BE931618 head_neck .h 1363 to 1812 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BU624742 cell lines, Enchondroma .h 1394 to 1999 624 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 606/606
(100 %)
0 diff
(100 %id)
TI_149287524   .h 1415 to 2312 963 to 76   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 888/1129
(78 %)
5 diff
(99.6 %id)
TI_154039153   .h 1458 to 2312 909 to 63   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 847/931
(90 %)
15 diff
(98.4 %id)
TI_149284222   .h 1478 to 2312 911 to 84   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 828/832
(99 %)
4 diff
(99.6 %id)
D31527   .h 1525 to 1755 1 to 232       232/232
(100 %)
4 diff
(98.3 %id)
AI217948   .h 1536 to 2002 467 to 1       467/467
(100 %)
7 diff
(98.6 %id)
AI348250 adenocarcinoma, colon .h 1541 to 1992 452 to 1       452/452
(100 %)
0 diff
(100 %id)
TI_149293102   .h 1547 to 2312 907 to 143   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 765/807
(94 %)
42 diff
(94.8 %id)
TI_149299585   .h 1558 to 2312 834 to 90   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 745/936
(79 %)
5 diff
(99.5 %id)
CN305483 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .h 1563 to 2305 1 to 744       744/744
(100 %)
8 diff
(99.0 %id)
AA249191   .h 1568 to 1884 1 to 326       326/326
(100 %)
13 diff
(96.1 %id)
BQ301321 bocio_tumor .h 1576 to 1718 1 to 148       148/152
(97 %)
8 diff
(94.8 %id)
D79291 aorta .h 1580 to 1890 1 to 309       309/309
(100 %)
4 diff
(98.8 %id)
AA096228   .h 1587 to 1791 1 to 202       202/202
(100 %)
4 diff
(98.1 %id)
AI285258 adenocarcinoma, colon .h 1589 to 1992 404 to 1       404/404
(100 %)
0 diff
(100 %id)
R65862 placenta .h 1600 to 1954 1 to 368       368/377
(97 %)
22 diff
(94.2 %id)
H03336 placenta .h 1602 to 1923 1 to 326       326/355
(91 %)
10 diff
(97.2 %id)
TI_149304964   .h 1605 to 2317 811 to 100       712/1026
(69 %)
0 diff
(100 %id)
AA938883 pooled .h 1608 to 1999 393 to 1       393/394
(99 %)
3 diff
(99.3 %id)
AI700629 carcinoid, lung .h 1610 to 2083 1 to 474     Submitted on the opposite strand 474/474
(100 %)
2 diff
(99.6 %id)
TI_149284209   .h 1610 to 2312 785 to 85   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 701/811
(86 %)
8 diff
(99.1 %id)
BE504547 carcinoid, lung .h 1611 to 2122 1 to 512     Submitted on the opposite strand 512/512
(100 %)
0 diff
(100 %id)
BU631681 cell lines, Chondrosarcoma .h 1613 to 2315 721 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 703/703
(100 %)
0 diff
(100 %id)
BM978459 lung, Primary Lung Epithelial Cells .h 1614 to 2317 716 to 14       703/716
(98 %)
0 diff
(100 %id)
CA445079 lung, Metastatic Chondrosarcoma .h 1615 to 2312 715 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 699/699
(100 %)
1 diff
(99.9 %id)
BM972833 lung .h 1620 to 2312 709 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 693/693
(100 %)
3 diff
(99.6 %id)
BU625262 cell lines, Enchondroma .h 1621 to 2312 711 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 693/693
(100 %)
1 diff
(99.9 %id)
BQ014025 Chondrosarcoma, Left Pubic Bone .h 1635 to 2312 693 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 677/677
(100 %)
3 diff
(99.6 %id)
CA425187 Bone, Subchondral Bone .h 1638 to 2312 693 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 675/675
(100 %)
1 diff
(99.9 %id)
CA428184 Bone, Subchondral Bone .h 1639 to 2312 692 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 674/674
(100 %)
0 diff
(100 %id)
BU680390 lung, Primary Lung Epithelial Cells .h 1666 to 2312 663 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 647/647
(100 %)
4 diff
(99.4 %id)
AA426315 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1672 to 1982 48 to 358       311/358
(86 %)
6 diff
(98.4 %id)
CA418834 Chondrosarcoma Grade II, Left Pelvis .h 1674 to 2315 660 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 642/650
(98 %)
2 diff
(99.7 %id)
BQ717441 sympathetic trunk .h 1677 to 2312 1 to 636   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 636/636
(100 %)
2 diff
(99.7 %id)
AI285212 adenocarcinoma, colon .h 1681 to 1992 312 to 1       312/312
(100 %)
2 diff
(99.4 %id)
BM312748 Pancreas, Purified pancreatic islet .h 1696 to 2216 12 to 531       520/531
(97 %)
6 diff
(98.9 %id)
BI816689 brain, glioblastoma without EGFR amplification .h 1701 to 2312 616 to 1       616/616
(100 %)
5 diff
(99.2 %id)
AI261236 adenocarcinoma, colon .h 1717 to 1992 276 to 1       276/276
(100 %)
0 diff
(100 %id)
CK822183 Pancreas, Purified pancreatic islet .h 1744 to 2313 1 to 570     Submitted on the opposite strand 570/573
(99 %)
1 diff
(99.9 %id)
BU071326 insulinoma, Pancreas .h 1755 to 2312 574 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 559/559
(100 %)
1 diff
(99.9 %id)
BU680403 lung, Primary Lung Epithelial Cells .h 1759 to 2312 571 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 555/555
(100 %)
1 diff
(99.9 %id)
BM709815 eye, Retina Foveal and Macular .h 1764 to 2274 1 to 511       511/511
(100 %)
1 diff
(99.9 %id)
BQ447389 Knee, Osteoarthritic Cartilage .h 1764 to 2312 569 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 552/552
(100 %)
3 diff
(99.5 %id)
BM975895 lung, Primary Lung Cystic Fibrosis EpithelialCells .h 1771 to 2312 553 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 537/537
(100 %)
2 diff
(99.7 %id)
BU727661 eye, eye anterior segment .h 1772 to 2314 544 to 1   fully sequenced,   544/544
(100 %)
4 diff
(99.3 %id)
AA551147 Schwannoma tumor .h 1776 to 2311 535 to 1       535/535
(100 %)
1 diff
(99.9 %id)
T77407 whole brain .h 1805 to 1999 1 to 205       205/205
(100 %)
13 diff
(93.7 %id)
AI554308 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .h 1807 to 2238 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AI660897 colon, colonic mucosa from 5 ulcerative colitispatients .h 1807 to 2317 514 to 3       512/514
(99 %)
0 diff
(100 %id)
BU682456 lung .h 1819 to 2312 510 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 494/494
(100 %)
3 diff
(99.4 %id)
CN305484 embryonic stem cells, DMSO-treated H9 cellline .h 1827 to 2285 1 to 459       459/459
(100 %)
2 diff
(99.6 %id)
AI674224 Prostate .h 1827 to 2312 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AI809609 pooled .h 1827 to 2313 491 to 4       488/491
(99 %)
0 diff
(100 %id)
AA814952 germinal center B cell .h 1828 to 2312 499 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 485/485
(100 %)
1 diff
(99.8 %id)
N93190 parathyroid gland, parathyroid tumor .h 1836 to 2317 475 to 2       474/477
(99 %)
0 diff
(100 %id)
BP390411 pancreatic islet .h 1850 to 2296 1 to 447     Submitted on the opposite strand 447/447
(100 %)
0 diff
(100 %id)
T87389 liver and spleen .h 1853 to 2075 1 to 231   fully sequenced,   231/231
(100 %)
0 diff
(100 %id)
EL949343 eyeball .h 1855 to 2296 7 to 448   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 442/448
(98 %)
1 diff
(99.8 %id)
AI814776 adenocarcinoma, Pancreas .h 1857 to 2312 456 to 1       456/456
(100 %)
1 diff
(99.8 %id)
BU617478 Bone, Subchondral Bone .h 1867 to 2312 464 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
AA478597 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 1873 to 2312 439 to 1       439/439
(100 %)
1 diff
(99.8 %id)
AI076807 liver and spleen .h 1874 to 2317 446 to 3       444/446
(99 %)
0 diff
(100 %id)
AI214208 adenocarcinoma, colon .h 1877 to 2312 436 to 1       436/436
(100 %)
0 diff
(100 %id)
BG499977 adenocarcinoma, Prostate .h 1884 to 2313 1 to 431       431/785
(54 %)
4 diff
(99.5 %id)
AI052794 liver and spleen .h 1886 to 2315 430 to 1       430/430
(100 %)
0 diff
(100 %id)
AW069449 bone marrow stroma .h 1890 to 2317 442 to 15       428/442
(96 %)
0 diff
(100 %id)
AI346961 adenocarcinoma, colon .h 1894 to 2313 423 to 4       420/423
(99 %)
0 diff
(100 %id)
TI_149305986   .h 1894 to 2312 503 to 85   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 419/963
(43 %)
0 diff
(100 %id)
BU686168 lung, Primary Lung Epithelial Cells .h 1894 to 2312 435 to 17   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 419/427
(98 %)
0 diff
(100 %id)
AL535353 brain, fetal brain .h 1896 to 2313 1 to 418       418/418
(100 %)
5 diff
(98.9 %id)
AA600209 lung, lung carcinoma .h 1896 to 2313 420 to 4       417/420
(99 %)
0 diff
(100 %id)
AI095606 uterus .h 1897 to 2317 428 to 8       421/428
(98 %)
0 diff
(100 %id)
AA776521   .h 1904 to 2312 408 to 1       408/408
(100 %)
2 diff
(99.6 %id)
AW079961 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .h 1907 to 2312 408 to 1       408/408
(100 %)
4 diff
(99.1 %id)
BM673110 eye, optic nerve .h 1914 to 2317 418 to 15       404/425
(95 %)
0 diff
(100 %id)
F00053 leg muscle, skeletal muscle .h 1918 to 2235 1 to 318       318/318
(100 %)
1 diff
(99.7 %id)
AI367916 adenocarcinoma, colon .h 1940 to 2310 373 to 3       371/373
(99 %)
0 diff
(100 %id)
AI249087 liver and spleen .h 1941 to 2312 372 to 1       372/372
(100 %)
2 diff
(99.5 %id)
AI538488 B-cell, chronic lymphotic leukemia .h 1942 to 2313 372 to 1       372/372
(100 %)
0 diff
(100 %id)
AI537254 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 1943 to 2315 375 to 1       375/375
(100 %)
2 diff
(99.5 %id)
AI675524 Prostate .h 1951 to 2310 362 to 3       360/362
(99 %)
0 diff
(100 %id)
N66611 multiple sclerosis lesions .h 1957 to 2312 356 to 1       356/356
(100 %)
2 diff
(99.5 %id)
AI872902 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .h 1960 to 2312 351 to 1       351/351
(100 %)
6 diff
(98.3 %id)
H03337 placenta .h 1963 to 2312 354 to 1       354/362
(97 %)
7 diff
(98.1 %id)
AA928726 adenocarcinoma, colon .h 1963 to 2313 351 to 1       351/351
(100 %)
0 diff
(100 %id)
T33275 brain .h 1965 to 2312 348 to 1       348/348
(100 %)
1 diff
(99.8 %id)
AA291162 germinal center B cell .h 1971 to 2312 341 to 1       341/341
(100 %)
1 diff
(99.8 %id)
AA904695 pooled .h 1976 to 2313 341 to 4       338/341
(99 %)
0 diff
(100 %id)
AV748681 Pituitary .h 1979 to 2143 1 to 157       157/160
(98 %)
8 diff
(95.0 %id)
AW469387 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .h 1987 to 2312 326 to 1       326/326
(100 %)
0 diff
(100 %id)
AI923259 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .h 1989 to 2313 326 to 2       325/326
(99 %)
0 diff
(100 %id)
R65771 placenta .h 1992 to 2312 327 to 1       327/330
(99 %)
18 diff
(94.6 %id)
BQ002501 Chondrosarcoma, Left Pelvis .h 1992 to 2317 339 to 14       326/339
(96 %)
0 diff
(100 %id)
AW197908 pooled .h 2016 to 2317 305 to 4       302/305
(99 %)
0 diff
(100 %id)
AI351966 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .h 2017 to 2313 296 to 1       296/301
(98 %)
0 diff
(100 %id)
AW874492 tumor, uterus .h 2035 to 2317 283 to 1       283/283
(100 %)
2 diff
(99.3 %id)
T79853 liver and spleen .h 2045 to 2317 274 to 1   fully sequenced,   274/274
(100 %)
2 diff
(99.3 %id)
AW078581 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .h 2045 to 2312 269 to 1       269/273
(98 %)
3 diff
(99.0 %id)
BF195793 Kidney .h 2054 to 2312 259 to 1       259/259
(100 %)
0 diff
(100 %id)
BF431679 Kidney .h 2074 to 2313 242 to 3       240/242
(99 %)
0 diff
(100 %id)
AI668831 Prostate .h 2091 to 2313 225 to 3       223/225
(99 %)
0 diff
(100 %id)
AA171695   .h 2099 to 2313 222 to 2     Submitted on the opposite strand 221/222
(99 %)
0 diff
(100 %id)
AA777306 liver and spleen .h 2131 to 2313 185 to 3       183/185
(98 %)
0 diff
(100 %id)
AI000844 breast .h 2131 to 2312 182 to 1       182/182
(100 %)
0 diff
(100 %id)
BG222831 brain, glioblastoma without EGFR amplification .h 2174 to 2313 140 to 1       140/140
(100 %)
0 diff
(100 %id)
D11925 Liver .h 2200 to 2312 1 to 113       113/113
(100 %)
0 diff
(100 %id)
BF911557 uterus_tumor .h 2210 to 2312 1 to 102   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 102/102
(100 %)
1 diff
(99.1 %id)
AW082221 pooled .h 2268 to 2743 1 to 476     Submitted on the opposite strand 476/476
(100 %)
3 diff
(99.4 %id)
AA011684 liver and spleen .h 2269 to 2677 1 to 412     Submitted on the opposite strand 412/412
(100 %)
11 diff
(97.4 %id)
AA682450 liver and spleen .h 2269 to 2614 1 to 346     Submitted on the opposite strand 346/346
(100 %)
3 diff
(99.2 %id)
AW006189 anaplastic oligodendroglioma, brain .h 2271 to 2685 1 to 415     Submitted on the opposite strand 415/415
(100 %)
2 diff
(99.6 %id)
BM023223 Islets of Langerhans, Pancreas .h 2272 to 2773 1 to 502   tiling clone, Submitted on the opposite strand 502/502
(100 %)
1 diff
(99.9 %id)
AA639746 colon, colon tumor RER+ .h 2275 to 2746 1 to 471     Submitted on the opposite strand 471/471
(100 %)
1 diff
(99.8 %id)
AA878474 carcinoid, lung .h 2371 to 2831 460 to 1   tiling clone,   460/460
(100 %)
5 diff
(99.0 %id)
AW078602 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .h 2497 to 2673 1 to 177     Submitted on the opposite strand 177/177
(100 %)
0 diff
(100 %id)
AW974462   .i-u 1 to 679 678 to 1 exact tiling clone, Submitted on the opposite strand 678/679
(99 %)
4 diff
(99.5 %id)
AA648524 germinal center B cell .i-u 259 to 608 350 to 1       350/350
(100 %)
4 diff
(98.9 %id)
AA805710 germinal center B cell .i-u 268 to 679 412 to 1 exact     412/412
(100 %)
0 diff
(100 %id)
DA258115 caudate nucleus .j 1 to 577 2 to 579   tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
BF591401 colon, colon tumor, RER+ .k 1 to 532 532 to 1 exact tiling clone,   532/532
(100 %)
1 diff
(99.9 %id)
BE093690 breast .l-u 1 to 330 1 to 325 exact tiling clone,   325/336
(96 %)
7 diff
(98.0 %id)
CR988684 T-Lymphocytes Gene SPEN, variant not shown         Suspected internal deletion, this clone was ignored    
BF325587 amnion_normal Gene SPEN, variant not shown         Suspected internal deletion, this clone was ignored    
BG943025 blood Gene SPEN, variant not shown       AAA Suspected internal deletion, internal priming: the 3' end of the oligo dt primed clone lies in the CDS, this clone was ignored    
AV649219 corresponding non cancerous liver tissue Gene SPEN, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BE810945 amnion_normal Gene SPEN, variant not shown         Suspected internal deletion, this clone was ignored    
AV650962 corresponding non cancerous liver tissue Gene SPEN, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
CR735767   Gene SPEN, variant not shown       AAA This clone was ignored    
AF085964   Gene SPEN, variant not shown       AAA This clone was ignored    
W92026 liver and spleen Gene SPEN, variant not shown         Suspected internal deletion, this clone was ignored    
W92087 liver and spleen Gene SPEN, variant not shown         Suspected internal deletion, this clone was ignored    
W86989 liver and spleen Gene SPEN, variant not shown         This clone was ignored    
AA778897 liver and spleen Gene SPEN, variant not shown         This clone was ignored    
AI032509 liver and spleen Gene SPEN, variant not shown         This clone was ignored    
AI056243 liver and spleen Gene SPEN, variant not shown         This clone was ignored    
AI076584 liver and spleen Gene SPEN, variant not shown         This clone was ignored    
AI248283 liver and spleen Gene SPEN, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e, .f, .g-u, .h, .i-u, .j, .k, .l-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI